Tyra Biosciences, Inc.

Historical 13F Holders

Symbol
TYRA
CUSIP
90240B106
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 90240B106 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
19.9% 9/17/2026
Event 9/15/2026
FMR LLC 13G
14.4% 4/7/2026
Event 3/31/2026
Janus Henderson Group PLC 13G/A 7.2% 5/15/2026
Event 3/31/2026
Farallon Capital Partners, L.P. 13G/A
6.6% 5/12/2026
Event 3/31/2026
Biotechnology Value Fund L P 13G
6.1% 9/21/2026
Event 9/14/2026
Nextech VI Oncology SCSp 13G/A
6.0% 8/14/2026
Event 6/30/2026
Paradigm Biocapital Advisors LP 13G
5.8% 9/17/2026
Event 9/10/2026
TCG Crossover GP I, LLC 13G
5.7% 3/6/2025
Event 2/27/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
BlackRock, Inc. 13G/A 4.8% 10/27/2026
Event 9/30/2026
Todd Harris 13G/A 4.8% 5/14/2026
Event 3/31/2026
Vestal Point Capital, LP 13G/A
4.5% 11/14/2025
Event 9/30/2025
Commodore Capital LP 13G/A
4.2% 5/15/2026
Event 3/31/2026
Canaan XI L.P. 13G/A
1.4% 4/24/2026
Event 3/31/2026
Farallon Capital Management, L.L.C. 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 158 78.9 M $1.73B
2026 Q2 170 69.3 M $2.22B
2026 Q1 164 66.0 M $2.53B
2025 Q4 134 56.8 M $1.49B
2025 Q3 116 55.6 M $778M
2025 Q2 122 56.6 M $542M
2025 Q1 119 53.6 M $500M
2024 Q4 115 48.6 M $676M
2024 Q3 98 47.1 M $1.11B
2024 Q2 80 46.8 M $749M
2024 Q1 78 46.9 M $768M
2023 Q4 65 35.8 M $495M
2023 Q3 60 36.5 M $502M
2023 Q2 60 36.2 M $617M
2023 Q1 52 35.7 M $573M
2022 Q4 47 35.2 M $268M
2022 Q3 50 35.7 M $314M
2022 Q2 49 35.7 M $256M
2022 Q1 47 36.1 M $387M
2021 Q4 46 35.2 M $494M
2021 Q3 27 26.1 M $457M